[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ELVN":3,"homepage-market-summary":31,"stock-news-ELVN":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"ELVN","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Enliven Therapeutics, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.","67","Burlingame, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},46.97,47.38,47.43,45.92,46.21,0.76,1.64,1123168.878773,12586,46.8264,62.32,14.785,1106628.547769996,67.7,1648,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":155},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,145,150],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":143,"price":144,"is_up":40},"Real Estate","XLRE",0.32,40.81,{"name":146,"etf":147,"change":148,"price":149,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":151,"etf":152,"change":153,"price":154,"is_up":40},"Comm Services","XLC",0.35,110.32,[156,161,165,169],{"ticker":157,"name":158,"price":159,"change":160,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":162,"name":163,"price":164,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":166,"name":167,"price":168,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":170,"name":171,"price":172,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":174,"articles":175},10,[176,182,187,192,198,204,210,216,221,225],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Enliven Therapeutics (Nasdaq:ELVN) - Stock Analysis - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikgFBVV95cUxPX0V3UDg5blBoYXNhckdheFZaLWFfRG41ZGNObmQ4c0FfeHllRHRwX0hWdnNUWFBReXBad21GRTRWcEZSUEZCRHpDZk9GSkVZdGR1Z3R4WWFmRzZhLWxjdDZPOGRibHZFYXNQbWFVb052SzA4WmpCdGt4ZmNQUHI2ekJHV1kySUpKdHRGT1BxOEo4Zw?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","Enliven Therapeutics (Nasdaq:ELVN) - Stock Analysis Simply Wall Street","Simply Wall Street",{"title":183,"link":184,"pubDate":179,"description":185,"source":186},"Enliven Therapeutics (ELVN) CFO exercises options, sells 6,018 shares - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiugFBVV95cUxNUUYwRGRFQnVHNnJNVG5tWWItYXBOam1DMkNjRm1OU3JkV1JoYldQd3JEdVdQdFJ6cFRST0swM3VLME9WemF3ZVZBZ0M3bFJEUkxKclc1ekxnMkhERUF4WU5nSUVyQ1E2R2VCTFRaS1RObHNraGlZamNhd3c2Slc0SkhxZHNqTVY2ZEVCcGJnZU1kTVZ5MlVqNnJWR1BGSGloUnZCNzNsZG9PakdDYnI5ak1FM0xzZGhaWFE?oc=5","Enliven Therapeutics (ELVN) CFO exercises options, sells 6,018 shares Stock Titan","Stock Titan",{"title":188,"link":189,"pubDate":179,"description":190,"source":191},"Enliven Therapeutics Insider Sold Shares Worth $303,003, According to a Recent SEC Filing - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxQQ3pSa0d2OXhsS1ppT3BEZWV1Smh0eGk5T1h6dGZ2aFk2M0lLNDlHUlBuVkxBcEg4Z0Z5VEdxLWl4elF5YTRCaElSZl9QS2NuTUNpMWFRNk9ia0J2dm5CenV1Q3k2bDh3NWRVQk1GTFJuYnJmeVp2VC1yT09ocy1XZ1h4WlJSaUFiNUNQZTM0VmNORnJ5cXI1Z3ZiRF9sakMyZmZRaWdYY3M?oc=5","Enliven Therapeutics Insider Sold Shares Worth $303,003, According to a Recent SEC Filing Yahoo Finance","Yahoo Finance",{"title":193,"link":194,"pubDate":195,"description":196,"source":197},"Understanding the Setup: (ELVN) and Scalable Risk - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxOeVN3emZnZ2ROd21MVXp1NjZJUmsteE9fdXBvYVduVl9rN3NHdXBqUktwRi12anlHRE1LTF9kRTZHM2JHNHFUY0xrbHcyYlU4dlFuRXQwTmlpMTU5bUdHaFJZWnJvTTlqanl4YWhyN3JzRmNkeGxveEU3X0hhU0FzNzl2MHhHOTBQVWRRRy1FQ1pwM29DT1QzVDJEQ2RiRFQxUk5iYXFTY1NsVGVwNUNpbkloYkFxMlVPVEpZcHU3UE51WF9iRkE?oc=5","Thu, 01 Oct 2026 07:30:01 GMT","Understanding the Setup: (ELVN) and Scalable Risk Stock Traders Daily","Stock Traders Daily",{"title":199,"link":200,"pubDate":201,"description":202,"source":203},"Morgan Stanley initiates Enliven Therapeutics stock at overweight - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxObFhfbHJBOEJpM2tRNHItck5BWU9GdllKRFN4LUIyUkpHWU5uZ2hUQm53MFM4VmRlWEVUUGcwd1RJQlM5ekN3ci0zYndjSTBhSzZCdTk0eUd5MWxHc0ZXWGs2RWpEaVpXMVAwMmdIdnhqemRGUnRWUDFYTmNVTEF6eE1RUnlKZ3hvUlAwWFI1aWRoTDh3YnR3SjNYRTEzZ3haaHhtVjMwaVoxM3A0QURacFI4X0pnd0kwbFRITmJwR09VNzg?oc=5","Fri, 02 Oct 2026 07:46:12 GMT","Morgan Stanley initiates Enliven Therapeutics stock at overweight Investing.com","Investing.com",{"title":205,"link":206,"pubDate":207,"description":208,"source":209},"This Enliven Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiigJBVV95cUxNZVI3R1RPaEl4SnRiTk1WaTRIZG9ZZTR6MmljUFQ5bmJKZFpxNTQyT1BCVkJzUDFRVmpDVVF1cE4yMzE1U0xrV0ZESG1KeUk1dlYtMFRpQ3lzeGJpV1BSa1EyOVpiRnMyQkp4MW1vWmRXR3ZNbzR2WHZzUE1oWk1iaDV0dlRVMkZzLUQzMFJOdms5N3JmWWs0VXRYQ0FCaUhZVzlSWDhjeU1McVlRMndrbEcwUHlYbmhLdC1MX1NIV3ZXTWs3Tk5kRzNaZVlldmRwYXE1bmhkRFB0eWhUc0g5b1Rzb0pUd0tROUxXM2E3TmM2ckdGamN6aGI1TFpVOWVaSHFZVGl6aVg3Zw?oc=5","Fri, 02 Oct 2026 12:24:05 GMT","This Enliven Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Benzinga","Benzinga",{"title":211,"link":212,"pubDate":213,"description":214,"source":215},"ELVN Initiated Coverage by JP Morgan -- Rating Set to Overweight - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiogFBVV95cUxNV2Nwdm1ONGNBTW45cDZLM09hOG5FVmtVVG1FNjl6U005ZGV4a1duSnc1Qk5qN2x4Q0R0U1o4SDMyX2V3Q2NmV3pGdzVsNWd5YURhX2xSLXROa3VzTW5WcUpKU2kzdU5Mc2FselppamxGYmhwaU45SFM0eXNQRUxUeTZPQTJhZm5VRC1vTXY5cVAxSHk2RTlNanlvQmtib1MwRHc?oc=5","Thu, 01 Oct 2026 16:18:47 GMT","ELVN Initiated Coverage by JP Morgan -- Rating Set to Overweight GuruFocus","GuruFocus",{"title":217,"link":218,"pubDate":219,"description":220,"source":186},"Director Jeffrey Garland proposes selling 13,000 Enliven Therapeutics (NASDAQ: ELVN) shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiowFBVV95cUxQbElabGMtUHNnZGRqTHhGc2Q5Rk9qMEhNWHlGSEsxR1dJSWdMeHkyVkVEa2d3dWJXNnlGbmc4U0dvcFQ2bkYyYVBhYzJ3aXFrTUk4TmZtUW5HeWphNzIxYXgwWlF6MFRRQVpIbU9jZlVrRmJmOGJuNmU5Z2p0RHVFV0hua01Gc0EzMkFYVEZXM2w0TUNlNjNTd0tNS2U5TmE4WDlv?oc=5","Thu, 01 Oct 2026 20:03:14 GMT","Director Jeffrey Garland proposes selling 13,000 Enliven Therapeutics (NASDAQ: ELVN) shares. Stock Titan",{"title":222,"link":223,"pubDate":207,"description":224,"source":209},"This Enliven Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Frida - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiiAJBVV95cUxPYUwtSmZQa2RIWWx1SXgxeXZmTWlqaUhLMzFfNjFMb1VvRGQ1b1BwaGlmc08yNmdIVEhkNmY0Z0JlWnFGb0JRZmJYT3R1TC1wOG1XUW9YeUdxQVNkaExyQ1hNUmo0bGhNLWhwZWFFSTdNY0pjME9ZYkg1Y2M4MjRKNVNnTlY2X0VBUUc5UEZ4VzFLLXAyLWZNUmpvb2ZOcXFoLXNIVVpKM2dDTWFyUlN2N2REODZLZXJCU2RHWkZUdHZLanU2NGlaX21DUHluckRVbWVUeHh1VWRXYUFvU21ibzBrYkI0UWZzR2lOUWlmRHozYldYbTVURVVnb3VHQjhWamh5c0g0YlM?oc=5","This Enliven Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Frida Benzinga",{"title":226,"link":227,"pubDate":228,"description":229,"source":230},"Enliven Therapeutics CFO Benjamin Hohl sells $303,003 in stock By Investing.com - Investing.com Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxOZjA5OEVxTW9jblp5UzQwczhGQjFHTWhQc1R1V0luZ01JTkpIbmFDb3JVa0RWN1NGV3d6VW1PeXBhd2lrYm5hbWNYRTBWamp1X3hldm8zSTlaUFBnbWhXQjFwNFhrUV9rNFdSNFBpWDlJbnV6VWtLd2ttVkYxUHJoZ1lmNHhYOS1iVDhTVFY1a3dWXzhxT2xOU0VGYm9sNEdqMVh4T0Fqa0w1QVBPaXNFOGQ3Zk1UanEtZ3hfUHZB?oc=5","Tue, 22 Sep 2026 04:57:26 GMT","Enliven Therapeutics CFO Benjamin Hohl sells $303,003 in stock By Investing.com Investing.com Canada","Investing.com Canada"]